- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Sustainable Track Record
Chinese Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
Henan Lingrui Pharmaceutical
Market Cap: CN¥13.2b
Produces and sells medicines in China.
600285
CN¥23.43
7D
0.5%
1Y
-3.9%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥22.5b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥33.62
7D
5.3%
1Y
-5.1%
WuXi AppTec
Market Cap: CN¥176.2b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥61.65
7D
-0.6%
1Y
45.8%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥12.5b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥51.00
7D
-10.3%
1Y
-64.9%
Xiamen Amoytop Biotech
Market Cap: CN¥32.0b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥78.76
7D
12.3%
1Y
46.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥40.7b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥90.38
7D
2.4%
1Y
57.2%